BNP Paribas Financial Markets
WHWK

BNP Paribas Financial Markets’s Whitehawk Therapeutics WHWK Stock Holding History

BNP Paribas Financial Markets’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$697 Buy
202
+42
+26% +$131 ﹤0.01% 5508
2025
Q4 		$387 Hold
160
– – ﹤0.01% 5499
2025
Q3 		$304 Hold
160
– – ﹤0.01% 5352
2025
Q2 		$299 Hold
160
– – ﹤0.01% 5262
2025
Q1 		$285 Sell
160
-37
-19% -$97 ﹤0.01% 5185
2024
Q4 		$622 Buy
+197
New +$446 ﹤0.01% 5146
2022
Q4 		– Sell
-10,350
Closed -$146K – 4712
2022
Q3 		$146K Buy
+10,350
New +$136K ﹤0.01% 3624

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

BNP Paribas Financial Markets's WHWK Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Whitehawk Therapeutics (WHWK) stake by 26% in Q1 2026, buying an estimated $131 and bringing the position to 202 shares worth $697. The position accounts for ﹤0.01% of the portfolio, ranked #5508.

BNP Paribas Financial Markets first reported a position in WHWK in Q3 2022 and has held it in 7 quarters since. The position peaked at $146K in Q3 2022. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • BNP Paribas Financial Markets held 202 shares of Whitehawk Therapeutics worth $697 as of Q1 2026.
  • BNP Paribas Financial Markets bought 42 Whitehawk Therapeutics shares in Q1 2026, an estimated $131.
  • Whitehawk Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5508 holding.
  • BNP Paribas Financial Markets first reported a position in Whitehawk Therapeutics in Q3 2022 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Whitehawk Therapeutics position peaked at $146K in Q3 2022.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.